Palexia (Tapentadol Hydrochloride)

Tapentadol, the active ingredient in Palexia, is an opioid analgesic presented as a tablet for oral use. It is indicated for the management of moderate to severe acute pain in adult patients when alternative treatments are inadequate. GNH USA supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Tapentadol is an opioid analgesic that acts on the central nervous system to relieve pain.

- Acute postoperative pain: helps reduce pain intensity after surgical procedures. - Chronic musculoskeletal pain: provides long‑term relief for conditions such as osteoarthritis. - Cancer‑related pain: alleviates moderate to severe pain associated with malignancy.

Tapentadol may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Nausea - Dizziness - Constipation - Headache - Somnolence - Dry mouth

Serious or Rare Side Effects: - Respiratory depression - Seizures - Severe hypotension - Anaphylactic reactions - Serotonin syndrome - adrenal un‑un

When ​  ​     ​  ​     ​  …     … … … ...  ... … … … … … … … … … … … … …  … … … … … … … … … … …  t  t   …  …  ... … … … … … … …